This trial is designed to evaluate the use of umbilical cord mesenchymal stem cells for motor neurone disease. The trial is being conducted at General Hospital of Chinese Armed Police Forces in Beijing. Participants will receive multiple transplants of the cells via lumbar puncture. Participants will be monitored for complications, as well as changes in their clinical condition. The trial expects to enrol 30 subjects by invitation only.